Library / Laws / 118th Congress / Senate Bills / S. 148
S. 148
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2023-01-30 | 5.9K | ⠃⠗⠋ |
| Reported in Senate | 2023-01-30 | 11.7K | ⠃⠗⠋ |